The Department of Pediatric Cardiology and Cardiac Surgery was established in 2021 and is the leading in its field, where cardiac surgery is provided to children with congenital heart defects in newborns and children under the age of 18. Designed for 10 beds, including the intensive care and resuscitation service, equipped with the most modern equipment and instruments. Patients are treated according to WHO standards, which is updated annually. All conditions have been created here for carrying out medical surgical procedures at the highest level.
The staff of the Center have trained and work closely with leading clinics in the world. On the basis of advanced technologies, the following types of high-tech operations are performed for patients with heart defects:
Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,
(+998 95) 198-83-00